ar-turmerone has been researched along with tetradecanoylphorbol acetate in 1 studies
Studies (ar-turmerone) | Trials (ar-turmerone) | Recent Studies (post-2010) (ar-turmerone) | Studies (tetradecanoylphorbol acetate) | Trials (tetradecanoylphorbol acetate) | Recent Studies (post-2010) (tetradecanoylphorbol acetate) |
---|---|---|---|---|---|
41 | 0 | 29 | 31,050 | 61 | 2,217 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, Y; Kim, YH; Lee, SJ; Park, SY | 1 |
1 other study(ies) available for ar-turmerone and tetradecanoylphorbol acetate
Article | Year |
---|---|
Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-κB activation in TPA-induced breast cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Chromatin Immunoprecipitation; Curcuma; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Enzyme Activation; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Ketones; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Promoter Regions, Genetic; RNA, Small Interfering; Sesquiterpenes; Tetradecanoylphorbol Acetate; Tissue Inhibitor of Metalloproteinase-1; Transfection | 2012 |